Ludiomil (Maprotiline): An Atypical Tricyclic Antidepressant Ludiomil, known generically as maprotiline, represents a highly specialized pharmaceutical agent designed primarily for the treatment and management of moderate to severe major depressive disorder (MDD). Although structurally categorized as a tetracyclic antidepressant (TeCA) due to its unique four-ring configuration, it is historically and clinically grouped alongside traditional tricyclic […]
REMERON: Clinical Profile and Pharmacological Landscape of Mirtazapine Mirtazapine, clinically recognized and widely distributed under the brand name Remeron, stands as a prominent therapeutic agent within the category of atypical antidepressants. Specifically classified as a noradrenergic and specific serotonergic antidepressant (NaSSA), this compound represents a significant departure from conventional monoaminergic therapies. Its primary clinical indication […]
LUVOX (fluvoxamine) is an antidepressant medication that belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is used to treat major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). It works by increasing the levels of serotonin, a chemical messenger in the brain that helps regulate mood. LUVOX is typically prescribed […]
TRIAVIL: A Novel Antidepressant for the Treatment of Major Depressive Disorder Introduction Major depressive disorder (MDD) is a severe and disabling mental health disorder that affects millions of individuals worldwide. Despite advances in pharmacotherapy, many patients remain inadequately treated or fail to respond to standard therapies. TriaVIL (vilazodone hydrochloride) is a new antidepressant approved by […]
Unipolar depression is a mental health disorder characterized by a persistent low mood and loss of interest in activities. It is also known as major depressive disorder or clinical depression. It affects how a person thinks, feels and behaves, and can lead to a variety of physical and emotional problems. It can cause a person […]
PROFILE OF A DISORDER: Major Depressive Disorder Major Depressive Disorder (MDD) represents one of the most pervasive and debilitating mental health conditions globally, impacting millions of individuals across diverse populations. Defined by the presence of persistent, intense sadness and an overwhelming loss of pleasure or interest in nearly all activities—a condition known as anhedonia—MDD fundamentally […]
ACUTE DEPRESSION Acute depression, often conceptualized clinically as a severe and sudden onset of symptoms meeting the criteria for a major depressive episode (MDE), represents a critical challenge in mental health diagnosis and treatment. Unlike chronic or persistent forms of depression, the hallmark of the acute presentation is its rapid development and often intense severity, […]
Defining Recurrent Depression and Diagnostic Criteria Recurrent depression, formally categorized within the spectrum of Major Depressive Disorder (MDD), represents a chronic and significant psychological condition characterized by the experience of two or more distinct major depressive episodes (MDEs). This distinction from a single-episode MDD is critical for both prognosis and treatment planning, highlighting the persistent […]
Retarded Depression (Obsolete Terminology) The Core Definition and Obsolescence The designation Retarded Depression is an obsolete term in modern clinical psychology and psychiatry, historically used to describe a severe subtype of major depressive events characterized primarily by profound psychomotor slowing and associated vegetative symptoms, such as significant loss of appetite. While no longer used in […]
A collection of major episodes but the individual will not have experienced a manic episode, mixed episode or hypomanic episode. MAJOR DEPRESSIVE DISORDER: “A major depressive disorder can involve a variety of depressive symptoms however, they will not have suffered a manic episode.”
The AMURAKH Gene and Major Depressive Disorder The Core Definition of AMURAKH (AMK) The term AMURAKH (AMK) refers to a recently identified gene within the human genome that has garnered significant attention due to its strong association with the vulnerability and manifestation of major depressive disorder (MDD). Although psychiatric conditions often have complex, polygenic etiologies, […]
Brofaromine: A Comprehensive Encyclopedia Entry The Core Definition of Brofaromine Brofaromine is a novel psychotropic compound identified as a non-selective monoamine reuptake inhibitor, primarily targeting the transporters responsible for the reuptake of serotonin (5-HT) and norepinephrine (NE) in the brain. In essence, it acts by increasing the availability of these crucial neurotransmitters in the synaptic […]
Endogenous Depression Introduction: Defining Endogenous Depression Endogenous depression refers to a historical classification within the spectrum of Major Depressive Disorder (MDD), characterized by depressive symptoms that appear to arise from internal, biological factors rather than being precipitated by identifiable external stressors or life events. While the term itself is less commonly used as a primary […]